Neoton 500 (Phosphocreatine Sodium)

Phosphocreatine Sodium, the active ingredient in Neoton 500, is a metabolic agent presented as a sterile solution for intramuscular use. It is employed to support myocardial energy metabolism in patients with cardiac conditions such as ischemia, heart failure, or during cardiac surgery.

GNH USA supplies Neoton 500 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Neoton 500 is used to address cardiac energy deficits and protect myocardial tissue in several clinical scenarios.

Myocardial Ischemia: improves cellular energy supply during reduced blood flow. Heart Failure: supports cardiac muscle energetics to enhance contractile function. Cardiac Surgery: used perioperatively to protect the myocardium from ischemic injury.

Adverse reactions may occur following intramuscular administration of phosphocreatine sodium.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the site. - Local erythema: redness or mild swelling. - Nausea: transient upset stomach. - Dizziness: temporary light‑headedness. - Headache: mild to moderate intensity. - Low‑grade fever: short‑lasting temperature rise.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Cardiac arrhythmia: abnormal heart rhythm potentially life‑threatening. - Severe hypotension: marked drop in blood pressure. - Electrolyte imbalance: abnormal serum potassium or calcium levels. - Thrombophlebitis: inflammation of a vein with clot formation. - Renal impairment: reduced kidney function in susceptible individuals.

Prior to using Neoton 500, several safety considerations should be observed.

Allergy assessment: verify no known hypersensitivity to phosphocreatine. Cardiac monitoring: observe for arrhythmias during and after administration. Renal function: assess kidney function before use. Pregnancy and lactation: use only if benefits outweigh potential risks. Concomitant medications: review for agents affecting electrolyte balance. Store at ambient temperature: keep in original container, protect from light and moisture.

Phosphocreatine sodium may interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - High‑dose catecholamines: may exacerbate cardiac stress. - Potassium‑sparing diuretics: increased risk of hyperkalemia. - Anticoagulants: heightened bleeding risk at injection site.

Moderate Interactions (Monitor Closely): - Beta‑blockers: monitor heart rate and blood pressure. - ACE inhibitors: watch for additive hypotensive effects. - Electrolyte supplements: monitor serum electrolyte levels.